SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Roku, Inc. engages in the provision of a streaming platform for television. It operates through the following segments: Platform and Devices. The Platform segment includes the sale of digital advertising and distribution of streaming services. The Devices segment is involved in the sale of streaming players, Roku-made televisions, smart home products and services, audio products, and related accessories. The company was founded by Anthony J. Wood in October 2002 and is headquartered in San Jose, CA.

Roku Inc - Ordinary Shares - Class A

Roku Inc

Roku is seeing significant momentum as investors digest recent buyout rumors and a surge in positive sentiment surrounding its streaming platform and ad-tech capabilities. The community is actively debating the potential for an acquisition by major tech or media players, with many users pointing to its massive audience reach and advertising growth as key drivers for long-term value.

Intellia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is trending as investors digest a public stock offering of approximately 150 million dollars shortly after the company announced successful Phase 3 trial data for its hereditary angioedema therapy, Lonvo-z. The community is actively debating whether the dilution and management's timing represent a strategic move to fund long-term commercialization or a setback for retail shareholders amid heavy short interest.

What Is Tezos (XTZ)?   Tezos is a high-performing blockchain and open-source platform for assets and applications, with a strong focus on code security, on-chain governance, and decentralization. Tezos 2.0, the upcoming step in the evolution of Tezos, aims to improve scalability (via layer 2s), composability, and to implement support to mainstream programming languages (like Javascript, Typescript, Python, and many others).   Initially built with formal verification in mind, the Tezos protocol enables builders to avoid bugs when developing smart contracts, making it particularly suited to applications that require a high degree of security and certainty.   Tezos’ LPoS (Liquid Proof-of-Stake) consensus mechanism enables any stakeholder to take part, directly or by delegation, in the consensus process, and to be rewarded for securing the network. Rather uniquely, Tezos’ on-chain governance system also enables stakeholders to create and vote on protocol upgrade proposals. This pioneering system allows the protocol to self-amend and upgrade itself without leading to a split (or fork) in the blockchain, empowering the community without slowing down innovation.   First proposed in 2014 and launched in 2018, the Tezos Mainnet has a proven track record of running uninterrupted ever since, having earned a strong reputation for technical excellence and a supportive community.    Who Are the Founders of Tezos? Tezos was conceived by Arthur and Kathleen Breitman in a 2014 white paper under the pseudonym L.M. Goodman in a nod to Satoshi Nakamoto, referencing a journalist who had misidentified the creator of Bitcoin.   In a previous paper, the Breitmans had argued that Bitcoin's biggest shortcomings were the lack of a governance process that invited contributions from its community of users, cost and centralization issues raised by its proof-of-work system, the limited expressiveness of its programming language which didn’t allow for smart contracts, and security

Tezos

Tezos is experiencing intense community debate, with some traders targeting technical support levels and others highlighting long-term catalysts like the Clarity Act and staking yield potential. Discussions are characterized by polarized sentiment, as retail participants clash over whether the asset is facing further downside or preparing for a significant cycle reversal.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxcoin is seeing heightened market activity and community debate as investors react to the upcoming launch of its Goliath mainnet. While proponents view the infrastructure upgrade as a significant milestone for potential institutional adoption and staking utility, skeptics remain vocal, labeling the project as a persistent liquidity scam and warning against the volatility often seen around these event-driven cycles.

Terra is a decentralized financial payment network that rebuilds the traditional payment stack on the blockchain. Luna is the reserve currency of the Terra platform. It has three core functions: i) mine Terra transactions through staking, ii) ensure the price stability of Terra stablecoins and iii) provide incentives for the platform’s blockchain validators.

Terra Luna Classic

Terra Luna Classic is experiencing a surge in community engagement and price momentum, largely fueled by speculation surrounding a successful network upgrade and the upcoming anniversary of the Terra ecosystem collapse. Investors are actively discussing the potential for a massive token burn and increased exchange activity, with many holders maintaining high-conviction positions as part of a long-term comeback narrative.

J.P. Morgan Exchange-Traded Fund Trust - JPMorgan Nasdaq Equity Premium Income ETF

JPMorgan Nasdaq Equity Premium Income ETF

Investors are closely monitoring JEPQ as they weigh its monthly income potential against broader market volatility and Nasdaq growth exposure. The community is actively debating the optimal balance between JEPQ and similar income-focused ETFs, often discussing dividend sustainability and total return strategies for long-term portfolio growth.

NEOS ETF Trust - NEOS Nasdaq 100 High Income ETF

NEOS Nasdaq 100 High Income ETF

The NEOS Nasdaq 100 High Income ETF (QQQI) is attracting significant community attention due to its high monthly dividend yields and its role as a strategic tool for income-focused investors looking to hedge against tech volatility. Market participants are actively debating the trade-off between the fund's cash flow potential and the risk of price underperformance compared to the underlying Nasdaq-100 index, frequently comparing it to similar monthly income ETFs like JEPQ and SPYI.

The Render Network is a leading decentralized GPU compute platform for applications ranging from 3D rendering to machine learning and generative AI.  The network connects node operators looking to monetize their idle GPU compute power with artists and developers looking to scale intensive 3D rendering work and machine learning applications in the cloud. Through a decentralized peer-to-peer network, the Render Network achieves unprecedented levels of scale, speed, and economic efficiency. Facilitated by the Render Network Foundation, the ecosystem empowers artists and developers to build services and applications for the emerging digital economy.

Render Token (SOL)

Render is trending as investors debate its role as a fundamental DePIN and AI infrastructure play, with the community actively comparing its long-term utility against newer, high-risk AI agent projects. Despite price volatility, many are using market pullbacks to accumulate, viewing the token as a core asset for the next infrastructure-led crypto cycle.

Freeport-McMoRan, Inc. engages in the mining of copper, gold, and molybdenum. It operates through the following segments: U.S. Copper Mines, South America Operations, Indonesia Operations, Molybdenum Mines, U.S. Rod and Refining, Atlantic Copper, and Corporate and Other. The U.S. Copper Mines segment operates open-pit copper mines in Morenci, Bagdad, Safford, Sierrita, Miami in Arizona and Chino, and Tyrone in New Mexico. The South America Operations segment includes Cerro Verde in Peru and El Abra in Chile. The Indonesia Operations segment handles the operations of the Grasberg minerals district that produce copper concentrate containing significant quantities of gold and silver. The Molybdenum Mines segment includes the Henderson underground mine and Climax open pit mine, both in Colorado. The U.S. Rod and Refining segment consists of copper conversion facilities located in North America and includes refinery and rod mills. The Atlantic Copper segment smelts and refines copper concentrate and markets refined copper and precious metals in slimes. The Corporate and Other segment offers other mining and eliminations, oil and gas operations, and other corporate and elimination items. The company was founded by James R. Moffett on November 10, 1987, and is headquartered in Phoenix, AZ.

Freeport-McMoRan Inc

Freeport-McMoRan is experiencing heightened trading activity as the market aggressively prices in a long-term structural deficit for copper, driven by intensifying demand from AI data center infrastructure and global electrification. Investors are actively debating the stock's positioning against recent volume and margin headwinds, while institutional flows reflect strong conviction in its role as a key player in the ongoing pivot toward physical hard assets.

Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA), and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in Cleveland, OH.

Abeona Therapeutics Inc

Abeona Therapeutics is currently in the spotlight as investors analyze its transition from a clinical-stage developer to a commercial-ready company following the recent launch of ZEVASKYN. The community is actively debating the company's manufacturing ramp-up, the pace of patient onboarding at Qualified Treatment Centers, and management's guidance toward achieving profitability in 2026.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Celsius Holdings Inc. (CELH) Exceeds Market Returns: Some Facts to Consider

In the latest trading session, Celsius Holdings Inc. (CELH) closed at $29.18, marking a +2.75% move from the previous day.

CELH Stock Rises Premarket: Bernstein Says Alani Nu Can Offset Core Brand Slowdown

Equity

The firm sees a 55% upside for Celsius from its expanding multi-brand energy drink portfolio. 


INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Celsius Holdings, Inc. - CELH

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Celsius Holdings, Inc. - CELH INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Celsius Holdings, Inc. - CELH PR Newswire NEW YORK, June 11, 2026 NEW YORK, June 11, 2026 /PRNewswire...

Brokers Suggest Investing in Celsius (CELH): Read This Before Placing a Bet

The average brokerage recommendation (ABR) for Celsius (CELH) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

Celsius Holdings' Portfolio Reaches 20.9% Share: More Gains Ahead?

CELH hits a 20.9% U.S. energy-drink dollar share in Q1 2026 as Alani Nu surges. Retail resets are likely to add more shelf space.


Investors Heavily Search Celsius Holdings Inc. (CELH): Here is What You Need to Know

Zacks.com users have recently been watching Celsius (CELH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Zacks Investment Ideas feature highlights: Waste Connections, Matador Resources and Celsius

CEOs at Waste Connections, Matador Resources and Celsius recently bought shares, drawing attention to insider confidence and company outlooks.

Insider Watch: CEOs Are Buying These 3 Stocks

Recently, CEOs of several companies, namely Waste Connections, Matador Resources, and Celsius,  have made splashes, acquiring shares. What did they see?

Celsius Stock Stabilizes: Will Insider Buying Stop The Downward Trend?

Celsius Holdings is marginally higher in Tuesday's premarket as traders lean into a risk-on tape and focus on insider-buying signals.read more...

CELH and Zero-Sugar Energy Trends to Watch Through 2026

CELH is focusing on low- and zero-sugar energy, with its portfolio driving a large share of U.S. zero-sugar category growth in Q1 2026.


Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	$0.44	--	--	N/A
Q1 '26	$0.30	$0.41	36.88%	BEAT
Q4 '25	$0.19	$0.26	40.52%	BEAT
Q3 '25	$0.27	-$0.27	-200.80%	MISSED
Q2 '25	$0.21	$0.33	56.38%	BEAT

CELHCelsius Holdings Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q2 '26

Historical Earnings

Latest CELH News